Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells
1996

Enhancing Vinblastine Effectiveness with Phenytoin and Okadaic Acid

publication Evidence: moderate

Author Information

Author(s): K-I Kawamura, D Grabowski, K Weizer, R Bukowski, R Ganapathi

Primary Institution: Cleveland Clinic Foundation

Hypothesis

Can phenytoin and okadaic acid enhance the cytotoxic effects of vinblastine in human tumor cells?

Conclusion

Phenytoin and okadaic acid significantly enhance the cytotoxicity of vinblastine in human leukemia and lung cancer cells, leading to prolonged growth arrest and apoptosis.

Supporting Evidence

  • Phenytoin enhances vinblastine cytotoxicity without binding to P-glycoprotein.
  • Okadaic acid mimics phenytoin's effects on vinblastine cytotoxicity.
  • Both drugs lead to increased apoptosis in treated cells.
  • The combination of vinblastine and either drug results in persistent growth arrest.

Takeaway

This study shows that two drugs, phenytoin and okadaic acid, can make a cancer treatment called vinblastine work better by causing more cancer cells to die.

Methodology

Human leukemia HL-60 and lung cancer NSCLC-3 cells were treated with vinblastine, phenytoin, or okadaic acid, and analyzed for cytotoxicity, mitotic arrest, and apoptosis.

Limitations

The study primarily focuses on specific cancer cell lines and may not generalize to all types of tumors.

Participant Demographics

Human leukemia HL-60 cells and non-small-cell lung carcinoma NSCLC-3 cells.

Statistical Information

P-Value

0.001

Statistical Significance

p=0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication